CooperVision announced in a press release the forthcoming launch of MyDay MiSight 1 day contact lenses in the United Kingdom and select European and surrounding markets. This new myopia control soft contact lens combines the MiSight 1 day ActivControl Technology with the silicone hydrogel material used in MyDay lenses, the company says.
According to CooperVision, the company's ActivControl Technology has demonstrated an approximate 50% reduction in myopia progression. The lens design incorporates vision correction zones and treatment zones to provide clear vision while helping to control the worsening of myopia, the company says.
At launch in the UK and select European and surrounding markets, the product will be available in the following parameters:
|
Sphere Power Range |
Step Size |
|
-0.25 to -6.00 |
0.25D |
|
-6.50 to -10.00 |
0.50D |
"This innovation delivers 'always-on' myopia control—children benefit from treatment throughout the day, simply by wearing their contact lenses," says Jennifer Lambert, vice president, Myopia Management and Cornea Care, CooperVision. "It's also designed to help support a smooth transition from myopia management to adult lens wear, thanks to its shared material and specifications with MyDay lenses." OM